These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Recent advances in catalytic antibodies. Scanlon TS; Schultz PG Philos Trans R Soc Lond B Biol Sci; 1991 May; 332(1263):157-64. PubMed ID: 1678534 [TBL] [Abstract][Full Text] [Related]
3. The chemistry of the antibody molecule. Schultz PG; Yin J; Lerner RA Angew Chem Int Ed Engl; 2002 Dec; 41(23):4427-37. PubMed ID: 12458503 [TBL] [Abstract][Full Text] [Related]
9. Towards the generation of artificial O6-alkylguanine-DNA alkyltransferases: in vitro selection of antibodies with reactive cysteine residues. Damoiseaux R; Schultz PG; Johnsson K Chembiochem; 2002 Jun; 3(6):573-5. PubMed ID: 12325014 [No Abstract] [Full Text] [Related]
11. The kinetic basis of a general method for the investigation of active site content of enzymes and catalytic antibodies: first-order behaviour under single-turnover and cycling conditions. Topham CM; Gul S; Resmini M; Sonkaria S; Gallacher G; Brocklehurst K J Theor Biol; 2000 May; 204(2):239-56. PubMed ID: 10887904 [TBL] [Abstract][Full Text] [Related]
13. The use of biosensor technology for the engineering of antibodies and enzymes. Huber A; Demartis S; Neri D J Mol Recognit; 1999; 12(3):198-216. PubMed ID: 10398410 [TBL] [Abstract][Full Text] [Related]
14. Proteolysis activity of IgM antibodies from rheumatoid arthritis patients' sera: evidence of atypical catalytic site. Kamalanathan AS; Goulvestre C; Weill B; Vijayalakshmi MA J Mol Recognit; 2010; 23(6):577-82. PubMed ID: 21031477 [TBL] [Abstract][Full Text] [Related]